NCT00835822

Efficacy and Safety of the Use of Venocur Triplex® in Patients With Chronic Venous Insufficiency

Multicenter, Prospective, Randomized, Double-Blind Study to Assess the Therapeutic Efficacy and Safety of the Use of Venocur Triplex® in Patients With Chronic Venous Insufficiency

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 216 (actual)
• Sponsor: Abbott · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess the therapeutic efficacy and safety of Venocur Triplex®, administered BID for 60 days in patients with Chronic Venous Insufficiency rated between CEAP 2 and 4, in comparison to a Placebo group.

Conditions

• Venous Insufficiency

Interventions

Type	Name	Description
DRUG	Venocur Triplex®	Administered by oral route, two coated tablets per day, after the meals (breakfast and dinner), with some liquid, but not with alcoholic beverages.
DRUG	placebo	Administered by oral route, two coated tablets per day, after the meals (breakfast and dinner), with some liquid, but not with alcoholic beverages.

Timeline

• Start date: 2005-05-01
• Primary completion: 2006-10-01
• First posted: 2009-02-04
• Last updated: 2009-02-04

Locations

4 sites across 1 country: Brazil